In a filing, Lyra Therapeutics Inc revealed its Officer Palasis Maria acquired Company’s shares for reported $3545.0 on Apr 09 ’25. In the deal valued at $0.09 per share,39,567 shares were bought.
Jefferies downgraded its Lyra Therapeutics Inc [LYRA] rating to a Hold from a a Buy in a research note published on May 07, 2024; the price target was decreased to $0.50 from $10. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who decreased its forecast for the stock in early May from “a Buy” to “a Neutral”. BofA Securities also remained covering LYRA and has decreased its forecast on May 07, 2024 with a “an Underperform” recommendation from previously “Buy” rating. William Blair revised its rating on May 06, 2024. It rated LYRA as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of LYRA
On Monday, Lyra Therapeutics Inc [NASDAQ:LYRA] saw its stock jump 0.92% to $0.09. Over the last five days, the stock has lost -14.58%. Lyra Therapeutics Inc shares have fallen nearly -57.70% since the year began. Nevertheless, the stocks have fallen -98.38% over the past one year. While a 52-week high of $5.65 was reached on 01/02/25, a 52-week low of $0.08 was recorded on 04/09/25. SMA at 50 days reached $0.1603, while 200 days put it at $0.2247.
Levels Of Support And Resistance For LYRA Stock
The 24-hour chart illustrates a support level at 0.0833, which if violated will result in even more drops to 0.0794. On the upside, there is a resistance level at 0.0929. A further resistance level may holdings at 0.0986. The Relative Strength Index (RSI) on the 14-day chart is 29.39, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0131, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.73%. Stochastics %K at 8.11% indicates the stock is a buying.
How much short interest is there in Lyra Therapeutics Inc?
A steep rise in short interest was recorded in Lyra Therapeutics Inc stocks on 2025-03-31, growing by 0.54 million shares to a total of 2.41 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 1.88 million shares. There was a rise of 22.19%, which implies that there is a positive sentiment for the stock.
